iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). Since receiving FDA approval for the Company’s first breast cancer detection product in 2002, over 3,100 iCAD systems have been placed in healthcare practices worldwide. iCAD’s solutions aid in the early detection of the most prevalent cancers including breast, colon, prostate and in the future, lung cancer. For more information, call (877) iCADnow.
iCAD is the world's largest CAD company. We have an industry-leading Research and Development team giving iCAD a strong base of intellectual property as is evident in the 22 CAD-related patents awarded and the additional 20 patents in process.
98 Spit Brook Road,
Nashua NH 03062
For investor relations, please contact:
Anne Marie Fields
Lippert/Heilshorn & Associates, Inc.
+1 212-838 3777 phone